Author Correction: Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation

被引：0

作者：

Chengyu Shi ^{[1
]}

Ying Wang ^{[2
]}

Minjie Wu ^{[3
]}

Yu Chen ^{[1
]}

Fangzhou Liu ^{[2
]}

Zheyuan Shen ^{[3
]}

Yiran Wang ^{[1
]}

Shaofang Xie ^{[2
]}

Yingying Shen ^{[3
]}

Lingjie Sang ^{[1
]}

Zhen Zhang ^{[2
]}

Zerui Gao ^{[3
]}

Luojia Yang ^{[1
]}

Lei Qu ^{[2
]}

Zuozhen Yang ^{[3
]}

Xinyu He ^{[4
]}

Yu Guo ^{[5
]}

Chenghao Pan ^{[1
]}

Jinxin Che ^{[6
]}

Huaiqiang Ju ^{[7
]}

Jian Liu ^{[1
]}

Zhijian Cai ^{[1
]}

Qingfeng Yan ^{[1
]}

Luyang Yu ^{[1
]}

Liangjing Wang ^{[1
]}

Xiaowu Dong ^{[1
]}

Pinglong Xu ^{[1
]}

Jianzhong Shao ^{[5
]}

Yang Liu ^{[4
]}

Xu Li ^{[5
]}

Wenqi Wang ^{[5
]}

Ruhong Zhou ^{[8
]}

Tianhua Zhou ^{[9
]}

Aifu Lin ^{[7
]}

机构：

[1] Zhejiang University,MOE Laboratory of Biosystem Homeostasis and Protection, College of Life Sciences

[2] Zhejiang University,Cancer Center

[3] Key Laboratory for Cell and Gene Engineering of Zhejiang Province,Innovation Institute for Artificial Intelligence in Medicine

[4] Zhejiang University,Hangzhou Institute of Innovative Medicine, Institute of Drug Discovery and Design, College of Pharmaceutical Sciences

[5] Zhejiang University,Key Laboratory of Structural Biology of Zhejiang Province, Westlake Laboratory of Life Sciences and Biomedicine

[6] Westlake University,Institute of Immunology

[7] Zhejiang University School of Medicine,Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine and Institute of Gastroenterology

[8] Sun Yat-sen University Cancer Center,MOE Laboratory of Biosystems Homeostasis & Protection and Zhejiang Provincial Key Laboratory for Cancer Molecular Cell Biology, Life Sciences Institute

[9] State Key Laboratory of Oncology in South China,Department of Developmental and Cell Biology

[10] Collaborative Innovation Center for Cancer Medicine,Shanghai Institute for Advanced Study

[11] Zhejiang University-University of Edinburgh Institute (ZJU-UoE Institute),Department of Chemistry

[12] Zhejiang University School of Medicine,Institute of Quantitative Biology

[13] International Campus,Department of Cell Biology and Program in Molecular Cell Biology

[14] Zhejiang University,Department of Gastroenterology, the Second Affiliated Hospital, School of Medicine and Institute of Gastroenterology

[15] Zhejiang University,Breast Center of the First Affiliated Hospital, School of Medicine

[16] Zhejiang University,International School of Medicine, International Institutes of Medicine

[17] University of California,undefined

[18] Zhejiang University,undefined

[19] Colombia University,undefined

[20] Zhejiang University,undefined

[21] Zhejiang University School of Medicine,undefined

[22] Zhejiang University,undefined

[23] Zhejiang University,undefined

[24] The 4th Affiliated Hospital of Zhejiang University School of Medicine,undefined

[25] ZJU-QILU Joint Research Institute,undefined

来源：

Nature Communications | / 15卷 / 1期

关键词：

D O I：

10.1038/s41467-024-55049-5

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Anti-tumor immunotherapy by blockade of the PD-1/PD-L1 pathway with recombinant human PD-1-IgV
Zhang, C.
Wu, S.
Xue, X.
Li, M.
Qin, X.
Li, W.
Han, W.
Zhang, Y.
CYTOTHERAPY, 2008, 10 (07) : 711 - 719
[42] KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC (vol 15, 175, 2024)
Li, Jinghan
Shi, Daiwang
Li, Siyi
Shi, Xiang
Liu, Yu
Zhang, Yi
Wang, Gebang
Zhang, Chenlei
Xia, Tian
Piao, Hai-long
Liu, Hong-Xu
CELL DEATH & DISEASE, 2025, 16 (01):
[43] DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy
Huang, Kevin Chih-Yang
Chiang, Shu-Fen
Ke, Tao-Wei
Chen, Tsung-Wei
Hu, Ching-Han
Yang, Pei-Chen
Chang, Hsin-Yu
Liang, Ji-An
Chen, William Tzu-Liang
Chao, K. S. Clifford
ONCOIMMUNOLOGY, 2021, 10 (01):
[44] Dual blockade of PD-L1 and LAG-3 using a bispecific antibody improves anti-tumor immunity
Ni, Haiqing
Qiu, Yajing
Jing, Hua
Zhang, Pan
Chen, Bingliang
Wu, Zhihai
Zhou, Shuaixiang
Yu, Michael
Liu, Junjian
CANCER RESEARCH, 2020, 80 (16)
[45] Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma
Liang, Long
Kuang, Xinwei
He, Yi
Zhu, Lin
Lau, Poyee
Li, Xin
Luo, Dingan
Gong, Lan
Zhou, Wenbin
Zhang, Fanglin
Liang, Xiaowei
Li, Zhuofeng
Hu, Bin
Liu, Dandan
Ding, Tao
Li, Hui
Zhao, Shuang
Su, Juan
Hung, Mien-Chie
Liu, Jing
Liu, Hong
Chen, Xiang
NATURE GENETICS, 2025, 57 (03) : 680 - 693
[46] Albendazole induces an anti-tumor effect and potentiates PD-L1 blockade immunotherapy
Zhang, Weinan
He, Zhiqiang
Liang, Fucheng
Gong, Jie
Tan, Liuchang
Yang, Juan
Song, Siji
Xie, Luoyingzi
Lu, Yuangang
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (18) : 16763 - 16778
[47] Myeloid targeting in combination with PD1 inhibition boosts anti-tumor immunity in melanoma
Krykbaeva, I.
Damsky, W.
Turner, N.
Perry, C.
Kluger, H.
Bosenberg, M.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : B19 - B19
[48] Novel Strategy to Regulate PD-L1 Expression and Enhance Anti-Tumor Effect
Sredni, Benjamin
Chaouat, Abigael
Hay, Ophir
Manoim, Julia
Nadler, Ronia
Kalechman, Yona
JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
[49] Albendazole induces an anti-tumor effect and potentiates PD-L1 blockade immunotherapy
Weinan Zhang
Zhiqiang He
Fucheng Liang
Jie Gong
Liuchang Tan
Juan Yang
Siji Song
Luoyingzi Xie
Yuangang Lu
Journal of Cancer Research and Clinical Oncology, 2023, 149 : 16763 - 16778
[50] Robust anti-tumor immunity through the integration of targeted lipid nanoparticle-based mRNA nanovaccines with PD-1/PD-L1 blockade
Jin, Chengyan
Zhang, Yan
Li, Baofeng
Gao, Tianci
Wang, Bin
Hua, Peiyan
MATERIALS TODAY BIO, 2024, 27

← 1 2 3 4 5 →